Pandemic Perspectives: ‘No Pandemic-Driven Slowdown’ According To Simon-Kucher & Partners
In a discussion with Medtech Insight, partners at Simon-Kucher & Partners explained that the pandemic has, and will continue to, transform both the sales and revenue models of medtech.
You may also be interested in...
In a talk at the 2021 Advanced Technologies & Treatments for Diabetes conference, Medtronic's European director of medical affairs explained how its MiniMed 780G insulin pump can reduce long-term treatment costs for diabetics.
A new report from Informa's Meddevicetracker highlights strong projected growth in the market, explaining the underlying reasons why.
Massachusetts’ Medicaid program will cover reSET and reSET-O prescription digital therapeutics for the treatment of substance abuse disorder and opioid use disorder.